BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2970719)

  • 1. [Effect of hemosorption on the anti-chalone properties of the blood serum of patients with psoriasis].
    Khvatov EV; Ketlinskiĭ SA; Tret'iakova NN; Simbirtsev AS; Shostka GD
    Vestn Dermatol Venerol; 1988; (4):10-2. PubMed ID: 2970719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hemosorption on the state of lipid metabolism in patients with psoriasis].
    Lur'e VL; Korotkiĭ NG; Sharapova GIa
    Vestn Dermatol Venerol; 1985 Mar; (3):50-3. PubMed ID: 3993223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of hemosorption on the functional activity of leukocytes in psoriasis patients].
    Liukova TK
    Vopr Med Khim; 1991; 37(2):33-4. PubMed ID: 1897188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifying effect of the blood serum of patients with psoriasis on the inhibitory activity of epidermal chalones].
    Dosychev EA; Ketlinskiĭ SA; Tret'iakova NN
    Vestn Dermatol Venerol; 1981 Mar; (3):18-20. PubMed ID: 6455018
    [No Abstract]   [Full Text] [Related]  

  • 5. [The beta-blocker effect of the blood serum in patients with psoriasis].
    Sokolovskiĭ EV; Raznatovskiĭ IM; Tret'iakova NN
    Vestn Dermatol Venerol; 1989; (7):6-7. PubMed ID: 2573218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological activity of epidermal chalones in the presence of blood serum from patients with psoriasis].
    Tret'iakova NN
    Biull Eksp Biol Med; 1984 Jun; 97(6):754-5. PubMed ID: 6234950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of microcirculatory pathology and chalone regulation of epidermal cell proliferation in the pathogenesis of psoriasis].
    Dosychev EA; Eletskaia LV; Moshkalova IA; Topol'nitskiĭ NF; Tret'iakova NN
    Vestn Dermatol Venerol; 1983 Aug; (8):13-6. PubMed ID: 6227154
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current aspects of the use of hemosorption in the treatment of psoriasis].
    Korotkiĭ NG; Lopukhin IuM; Sharapova GIa; Molodenkov MN
    Vestn Dermatol Venerol; 1982 Jul; (7):13-6. PubMed ID: 7136249
    [No Abstract]   [Full Text] [Related]  

  • 9. [The content of fibronectin in the blood of patients with psoriasis].
    Vasil'eva NIu; Nazimova SV; Tatarinov IuS
    Lab Delo; 1991; (3):27-8. PubMed ID: 1710713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunochemical analysis of the proteinogram in patients with psoriasis after hemosorption].
    Petrunin DD; Lopukhin IuM; Molodenkov MN; Korotkiĭ NG; Sharapova GIa
    Biull Eksp Biol Med; 1982 Nov; 94(11):45-7. PubMed ID: 6185161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of using hemosorption in the clinical picture of severe forms of psoriasis].
    Novitskaia-Usenko LV; Nesterenko GB; Bashmakov GV; Kogon GKh; Ploskaia LM
    Vestn Dermatol Venerol; 1983 Feb; (2):57-9. PubMed ID: 6845876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunochemical status of psoriasis patients treated with hemosorption].
    Korotkiĭ NG; Petrunin DD
    Vestn Dermatol Venerol; 1983 Jun; (6):11-3. PubMed ID: 6225262
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined use of hemosorption and PUVA therapy in the treatment of patients with psoriasis].
    Korotkiĭ NG; Gast V; Bart I; Sergienko VI; Potapenko AIa
    Vestn Dermatol Venerol; 1983 Dec; (12):41-5. PubMed ID: 6673409
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidermic and lymphocytary chalone receptors in psoriasis].
    Vignale RA; Lasalvia E; Espasandin J; Borras A
    Med Cutan Ibero Lat Am; 1983; 11(4):233-40. PubMed ID: 6314069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First experience with the use of hemosorption in the treatment of psoriasis].
    Lopukhin IuM; Molodenkov MN; Evseev NG; Korotkiĭ NG; Shurkalina TKh
    Vestn Dermatol Venerol; 1980 Jan; (1):8-12. PubMed ID: 7368875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemosorption in the complex treatment of psoriatic arthritis].
    Raznatovskiĭ IM; Shostka GD; Lukichev BG; Khvatov EV; Vasil'ev AN
    Vestn Dermatol Venerol; 1986; (3):43-6. PubMed ID: 3716569
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psoriasis treatment by hemosorption using a synthetic charcoal hemosorbent].
    Glukhen'kiĭ BT; Krishtof AN; Amalian VA; Karpenko VV; Nemchikov MIu
    Vestn Dermatol Venerol; 1982; (12):10-3. PubMed ID: 6984260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the functional activity of neutrophils during hemosorption therapy of patients with systemic rheumatic and other diseases with immunologic disorders].
    Mogireva IA; Barsukov AA; Dmitriev AA; Zemskov VM
    Ter Arkh; 1985; 57(8):30-3. PubMed ID: 2933840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunochemical identification of proteins adsorbed on columns of activated charcoal during hemosorption in patients with psoriasis].
    Petrunin DD; Molodenkov MN; Olefirenko GA
    Vopr Med Khim; 1982; 28(6):33-7. PubMed ID: 6818763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sorption immunocorrection and rheological properties of the blood in patients with disseminated psoriasis].
    Glukhen'kiĭ BT; Amalian VA; Karpenko VV
    Vestn Dermatol Venerol; 1984 Nov; (11):16-7. PubMed ID: 6528731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.